Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of ProKidney Corp (NASDAQ: PROK) was $2.6 for the day, up 7.44% from the previous closing price of $2.42. In other words, the price has increased by $7.44 from its previous closing price. On the day, 1.79 million shares were traded. PROK stock price reached its highest trading level at $2.6597 during the session, while it also had its lowest trading level at $2.37.
Ratios:
Our analysis of PROK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.48 and its Current Ratio is at 11.48.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.Guggenheim initiated its Buy rating on September 10, 2024, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 08 ’25 when Weber Darin J. sold 103,480 shares for $3.02 per share. The transaction valued at 312,510 led to the insider holds 0 shares of the business.
DARIN J WEBER bought 103,480 shares of PROK for $62,761 on Jul 08 ’25. On Apr 22 ’25, another insider, Control Empresarial de Capital, who serves as the Add’l Rep. Persons-see Ex.99-1 of the company, bought 387,393 shares for $0.71 each. As a result, the insider paid 276,366 and bolstered with 73,842,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 788896320 and an Enterprise Value of 1402626176. For the stock, the TTM Price-to-Sale (P/S) ratio is 1443.64. Its current Enterprise Value per Revenue stands at 2661.53 whereas that against EBITDA is -8.241.
Stock Price History:
The Beta on a monthly basis for PROK is 1.77, which has changed by 0.5562701 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is 0.74%, while the 200-Day Moving Average is calculated to be 59.13%.
Shares Statistics:
PROK traded an average of 13.42M shares per day over the past three months and 1286100 shares per day over the past ten days. A total of 133.42M shares are outstanding, with a floating share count of 99.34M. Insiders hold about 26.41% of the company’s shares, while institutions hold 30.46% stake in the company. Shares short for PROK as of 1757894400 were 10116244 with a Short Ratio of 0.75, compared to 1755216000 on 8691695. Therefore, it implies a Short% of Shares Outstanding of 10116244 and a Short% of Float of 10.5.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of ProKidney Corp (PROK) in the stock market.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.09 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.44 and -$0.63 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.57, with 6.0 analysts recommending between -$0.38 and -$0.75.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of -$32.5k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is -$230k.
